L.I.A. Pure Capital Ltd. Exits Position in Clearmind Medicine Inc. (CMND)

L.I.A. Pure Capital Ltd. has filed a Schedule 13G/A (Amendment No. 3) with the SEC, indicating that it no longer holds a reportable beneficial ownership position in Clearmind Medicine Inc. (CMND). As of the event date of March 31, 2026, the reporting person disclosed owning 0 shares of common stock, representing 0.0% of the total shares outstanding. This filing serves as an exit statement, confirming that the filer has ceased to be the beneficial owner of more than five percent of the class of securities. L.I.A. Pure Capital Ltd., an Israeli-based corporation led by CEO Kfir Silberman, previously maintained a significant stake but has now fully liquidated its position or reduced it below the reporting threshold. The filing was made under Rule 13d-1(c), certifying that the securities were not held for the purpose of changing or influencing the control of the issuer. Clearmind Medicine Inc. is a Vancouver-based company focused on psychedelic-derived therapeutics.